Hertz Rachel, Ben-Haim Nadav, Petrescu Anca D, Kalderon Bella, Berman Inna, Eldad Naama, Schroeder Friedhelm, Bar-Tana Jacob
Department of Human Nutrition and Metabolism, Hebrew University Medical School, Jerusalem 91120, Israel.
J Biol Chem. 2003 Jun 20;278(25):22578-85. doi: 10.1074/jbc.M212138200. Epub 2003 Apr 15.
Missense mutations of the ligand binding domain of hepatocyte nuclear factor (HNF)-4alpha result in maturity onset diabetes of the young (MODY)-1. We show here that MODY-1 as well as Gln-185 missense mutants of the ligand binding domain of HNF-4alpha fail to transactivate transcription of HNF-4alpha-responsive genes. Defective transactivation by these mutants is accounted for by their reduced binding affinities for fatty acyl agonist ligands of HNF-4alpha. These mutants may be rescued by exogenous fatty acid agonist ligands of HNF-4alpha, yielding transcriptional activities in the wild type range. The effect of added ligands is synergistic with that of transcriptional coactivators of HNF-4alpha. These findings may indicate the means for treating selected MODY-1 subjects with HNF-4alpha agonist nutrients and drugs.